What does MPM BioImpact LLC hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

MPM BioImpact LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

DBV Technologies S A

$109M5.2M8.4%

Cullinan Therapeutics, Inc.

$109M7.6M8.4%

Aktis Oncology, Inc.

$87M4.8M6.7%

Liquidia Corporation

$53M1.4M4.1%

Alumis Inc

$53M2.4M4.1%

Edgewise Therapeutics Inc

$52M1.7M4.0%

Revolution Medicines, Inc.

$49M507K3.8%

Agios Pharmaceuticals Inc

$44M1.3M3.4%

Corcept Therapeutics, Inc.

$40M986K3.1%

Trevi Therapeutics Inc

$39M3.3M3.0%

Filing history loading…